
Dopamine When You See Certain People Harmed
Witnessing harm to others triggers dopamine release in the brain, particularly in individuals with high empathy and prosocial tendencies
Dr. Matthew Hill provides a comprehensive scientific overview of how cannabis affects the brain and body, distinguishing between the effects of its primary active compounds THC and CBD. The episode begins by explaining the basic neurobiology of cannabis, including how THC interacts with CB1 receptors in the brain to produce the psychoactive high, which involves alterations in time perception, focus, memory consolidation, appetite stimulation, and stress response. CBD operates through different mechanisms and does not produce the same intoxicating effects as THC.
A significant portion of the discussion focuses on the practical differences between cannabis administration methods. Smoking and vaping deliver cannabinoids relatively quickly into the bloodstream through the lungs, typically producing effects within minutes. Edibles, by contrast, are metabolized through the digestive system and liver, resulting in delayed onset that can take one to two hours or longer, though the effects typically last much longer than inhaled forms. This distinction is crucial for understanding user experience and potential for overconsumption with edibles.
The episode addresses major health concerns associated with cannabis use, particularly the relationship between THC and mental health conditions. Dr. Hill discusses research on cannabis and psychosis, explaining how heavy THC use, especially during adolescence when the brain is still developing, may increase risk for psychotic disorders and schizophrenia in vulnerable individuals. The discussion also covers cannabis-induced anxiety, bipolar depression, and the mechanisms behind these effects.
Addictive potential receives careful examination, with Dr. Hill explaining that while cannabis is not physically addictive like some substances, cannabis use disorder is a recognized condition affecting a percentage of users, particularly those who start using in adolescence or use high-potency products daily. High-potency THC products present increased risks compared to lower-potency cannabis.
The conversation includes discussion of CBD's potential clinical benefits, examining research on its effects for stress regulation, sleep improvement, and treatment of certain diseases. Dr. Hill addresses whether different cannabis strains produce meaningfully different biological effects, exploring the complex relationship between cannabinoid and terpene profiles. Hormonal impacts of cannabis use are discussed, including potential effects on reproductive hormones and other endocrine systems.
The episode concludes with examination of cannabis for therapeutic purposes, including management of chronic pain, stress, post-traumatic stress disorder, anxiety, and chemotherapy-induced nausea. Dr. Hill provides context about what research currently supports and what remains unclear, emphasizing that while cannabis may provide benefits for certain conditions, individual responses vary considerably based on genetics, previous experiences, and concurrent mental health conditions.
“THC works by binding to CB1 receptors in the brain to produce the psychoactive effects we associate with being high”
“The route of administration dramatically affects how quickly cannabis reaches the brain and how long the effects last”
“High-potency THC products carry significantly greater risk for adverse effects compared to lower-potency cannabis”
“Individual genetic factors play a major role in determining who is susceptible to cannabis-related mental health issues”
“CBD and THC have distinct biological mechanisms and should not be considered interchangeable in terms of effects and risks”